Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02625623 |
|---|---|
| Brief Title: | Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300) |
| First Submitted : | December 4, 2015 |
| First Submitted that Met QC Criteria : | December 4, 2015 |
| First Posted : | December 9, 2015 (Estimate) |
| Results First Submitted : | September 10, 2018 |
| Results First Submitted that Met QC Criteria : | September 10, 2018 |
| Results First Posted : | October 15, 2018 |
| Last Update Submitted that Met QC Criteria : | November 6, 2020 |
| Last Update Posted : | November 24, 2020 |